Interfant-21: International collaborative clinical trial for infants diagnosed with KMT2A-rearranged acute lymphoblastic leukaemia

  • Kotecha, Rishi (Primary Chief Investigator (PCI))
  • Moore, Andrew S. (Chief Investigator (CI))
  • Martin, Michelle (Chief Investigator (CI))
  • Lin Khaw, Seong (Chief Investigator (CI))
  • Strong, Robyn (Chief Investigator (CI))
  • Stutterheim, Janine (Chief Investigator (CI))
  • Henderson, Michelle (Chief Investigator (CI))
  • O'Connor, Matthew (Chief Investigator (CI))
  • Jones, Janelle (Project Manager)
  • May, Kylie (Project Manager)
  • Messina, Maria (Associate Investigator (AI))
  • Blakemore, Carolyn (Associate Investigator (AI))
  • Barbaric, Draga (Associate Investigator (AI))
  • Bateman, Caroline (Associate Investigator (AI))
  • Alvaro, Frank (Associate Investigator (AI))

Project: Research

Project Details

Short titleInterfant-21
StatusActive
Effective start/end date1/02/23 → 31/01/28

Clinical Trial Phase

  • Phase III (a & b)